13F-HR filed by KVP Capital Advisors, LP
KVP Capital Advisors, LP filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-13, with 32 holding rows worth $133,897,129.
- Accession
- 0001104659-26-060329
- Filer
- CIK 1858198
- Filed
- 2026-05-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 32 entries on the cover page, a total value of $133,897,129 stated on the cover page (in dollars after the unit check, H1), rows summing to $133,897,129 with VALUE read as dollars as filed, 13F file number 028-26641. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 440,000 | $23,196,800 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 42,900 | $13,821,951 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 2,165,997 | $7,472,690 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 36,200 | $6,118,524 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367201 | COMMON STOCK | 226,575 | $5,643,983 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 53,000 | $5,586,200 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 340,000 | $5,501,200 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 414,000 | $4,939,020 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 230,264 | $4,817,123 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 28,497 | $4,659,829 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 133,000 | $4,189,500 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 40,200 | $3,909,450 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 58,250 | $3,724,505 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 121,524 | $3,627,491 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 605,280 | $3,304,829 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 4,750 | $2,816,655 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 91,000 | $2,703,610 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 79,700 | $2,655,604 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 500,000 | $2,645,000 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 300,000 | $2,541,000 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 125,000 | $2,445,000 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 31,813 | $2,321,395 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 373,128 | $2,220,112 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 45,000 | $2,212,200 | dollars as filed | |
| IMMIX BIOPHARMA INC | 45258H106 | COMMON STOCK | 230,423 | $2,099,154 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 59,700 | $1,998,756 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 26,900 | $1,935,455 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 505,431 | $1,359,609 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 462,355 | $1,359,324 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 32,700 | $1,315,521 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 4,000 | $456,560 | dollars as filed | |
| VYNE THERAPEUTICS INC | 92941V308 | COM | 500,551 | $299,079 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-26-060329 | this filing | 2026-05-13 | acceptance time not in the bulk data set |